CytomX Therapeutics, Inc. ($CTMX)
Filing Information
| Accession Number | 0001610717-26-000041 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
310,000
Total Value
$0.00
P&L
+inf% (+$1,379,500.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Scientific Officer | Common Stock | โ | Feb 2, 2026 | Grant/Award | 60,000 | $0.00 | $0.00 | 332,252 | Direct | โ | View Details | |
SVP, Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Feb 2, 2026 | Grant/Award | 250,000 | $0.00 | $0.00 | 250,000 | Direct | โ | View Details |